Day 1 :
Lions Club of Hyderabad Sadhuram Eye Hospital, India
Time : 9.00-09.45
Annavajjhala Venkatachalam is a Senior Consultant, Ophthalmic Surgeon and a Post-Graduate Teacher in Ophthalmology. He has completed his Master of Surgery in Ophthalmology from Gujarat University 30 years back and his fellowship in Cataract and Anterior Segment Surgeries from Aravind Eye Hospital, Madurai. He is a Senior Cataract Surgeon in Hyderabad for the last 30 years having performed nearly 50,000 + cataract surgeries. At present, he is Consultant and Chief Technical Advisor Lions Club of Hyderabad, Sadhuram Eye Hospital and Director of Hyderabad Eye Hospital.
Intra-operative Floppy Iris Syndrome (IFIS) is a nightmare for cataract surgeons all-around the world. The surgeon has to anticipate the complication and try to manage this unusual complication. In this paper, we will be discussing the different causes that lead to Intra Operative Floppy Iris Syndrome (IFIS) like systemic usage of alpha-I blockers, local pilocarpine eye drops etc., and intra-operative symptoms, signs and various ways of managing this complcation.
Boston University School of Medicine, USA
Babak Eliassi-Rad completed his medical degree at University of Wisconsin-Madison, the ophthalmology residency at Greater Baltimore Medical Center in Baltimore, Maryland, and glaucoma fellowship at Kresge Eye Institute in Detroitm, Michigan. He Currently is the director of glaucoma service at Boston University School of Medicine, Department of Ophthalmology. He has published 11 peer-reviewed papers in reputed journals and is on the editorial board of Eyewiki and a reviewer for Journal of Glaucoma.
Microinvasive Glaucoma Surgery (MIGS)
Glaucoma is one of leading causes of irreversible loss of vision and blindness worldwide. Glaucoma treatment is by lowering the intraocular pressure (IOP). This involves using medications, laser, or surgery. Glaucoma filtration surgery (trabeculectomy and/or glaucoma drainage implants) is the mainstay of surgical procedures for glaucoma. While effective in lowering the IOP, both procedures are associated with possible vision threatening complications. Therefore extensive research has been done to develop procedures that reduce IOP effectively and are safe. Microinvasive glaucoma surgery (MIGS) has emerged for the treatment of open-angle glaucoma (primary or secondary). MIGS is performed via an ab-interno approach, with minimal tissue disruption, therefore a more favorable risk profile, and faster recovery compared to conventional glaucoma surgery. It is usually combined with cataract surgery and performed in patients with mild to moderate glaucoma. The current MIGS devices lower IOP by different mechanisms. These include: Increasing conventional trabecular meshwork outflow via Schlemm’s Canal Device: Trabecular micro-bypass shunt (iStent, Glaukos, Laguna Hills, CA, USA), Hydrus micro-stent (Ivantus, Irvine, CA, USA), or ab-interno trabeculotomy: Trabectome (NeoMedix, Tustin, CA, USA), GATT (Gonioscopy-Assisted Transluminal Traculomotomy), Kahook Dual Blade (New World Medical, Rancho Cucamonga, CA, USA), Trab 360 (Sight Sciences, Menlo Park, CA, USA), and ABiC (ab-interno canaloplasty), (Ellex, Adelaide, Australia), Supraciliary microstenting: CyPass Micro-Stent (Alcon, Fort Worth, TX, USA), and iStent Supra (Glaukos, Laguna Hills, CA, USA). Use of subconjunctival space: Xen Gel Stent (Allergan, Irvine, CA, USA) and InnFocus MicroShunt (Santen, Miami, FL, USA).